Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T18:13:52.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:21:12.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:50:26.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T21:52:32.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating restricted access or a server-side issue preventing viewing the trial details. This change affects the user experience by preventing access to the main content on the page.
    Difference
    0.5%
    Check dated 2026-09-26T21:38:23.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, indicating access to the NCT04907968 listing is blocked; the new screenshot displays the error message and site chrome instead of the study details.
    Difference
    19%
    Check dated 2026-09-19T20:54:51.000Z thumbnail image

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.